Globus Medical’s (NYSE:GMED) Q4 Sales Beat Estimates
Medical device company Globus Medical (NYSE:GMED) reported Q4 CY2024 results , with sales up 6.6% year on year to $657.3 million. The company expects the full year’s revenue to be around $2.68 billion,
Exelixis stock holds firm with $41 target from JMP Securities
JMP Securities maintained a Market Outperform rating and a $41.00 price target for Exelixis (NASDAQ:EXEL) shares, aligning with the broader analyst consensus as five analysts have recently revised their earnings estimates upward.
BTIG Sticks to Its Buy Rating for Globus Medical (GMED)
In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price
Globus Medical (GMED) Q4 2024 Earnings Call Transcript
Operator Welcome to the Globus Medical's fourth quarter and full year 2024 earnings call. At this time, all lines will be on mute, and a Q&A session will be held after the prepared remarks. I will now turn the call over to Brian Kearns,
Globus Medical (GMED) Reports Q4 Earnings: What Key Metrics Have to Say
For the quarter ended December 2024, Globus Medical (GMED) reported revenue of $657.29 million, up 6.6% over the same period last year. EPS came in at $0.84, compared to $0.60 in the year-ago quarter.
JMP Securities Remains a Hold on Globus Medical (GMED)
In a report released today, David Turkaly from JMP Securities reiterated a Hold rating on Globus Medical (GMED – Research Report). The
JMP Securities Keeps Their Buy Rating on Evolent Health (EVH)
JMP Securities analyst Constantine Davides maintained a Buy rating on Evolent Health (EVH – Research Report) today and set a price target of ...
Digital Realty Trust’s (DLR) “Market Outperform” Rating Reiterated at JMP Securities
JMP Securities restated their market outperform rating on shares of Digital Realty Trust (NYSE:DLR – Free Report) in a ...
Shopify stock price target raised to $135 at JMP Securities
JMP Securities updated its outlook on Shopify (NYSE: NYSE:SHOP) shares, raising the price target to $135 from $120, while sustaining a Market Outperform rating. Currently trading at $123.59 and near ...
JMP Securities Raises Axon Enterprise, Inc. (AXON) Price Target to $725 on AI & Defense Demand
As the US stock markets were catching up with the tech disruption led by cheap Chinese AI models, US President Donald Trump’s ...
Yahoo Finance26d
JMP starts coverage on towers stock with 'marketperform' rating amid AI boom
Investing.com -- JMP Securities initiated coverage on digital infrastructure companies on AI related spending boom. Over the next five years, over $1 trillion in investments is expected ...
JMP Securities Reaffirms “Market Outperform” Rating for Blueprint Medicines (NASDAQ:BPMC)
JMP Securities reiterated their market outperform rating on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a ...
CoinDesk8d
Coinbase Benefits From Strong Near-Term Momentum, 2025 Is Off to a Good Start: JMP
The broker raised its Coinbase price target to $475 from $400 while maintaining its market outperform rating on the stock.
Yahoo Finance28d
Twilio price target raised to $165 from $110 at JMP Securities
https://www.tipranks.com/news/the-fly/t-mobile-price-target-raised-to-290-from-280-at-tigress-financial JMP Securities raised the firm’s price target on Twilio ...
Larimar Therapeutics (LRMR) Gets a Buy from JMP Securities
In a report released today, Jonathan Wolleben from JMP Securities reiterated a Buy rating on Larimar Therapeutics (LRMR – Research Report), ...